Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

BNP-7787 to enter phase III clinical trials as chemoprotectant

May 16, 2000

Lambda synthesizes photosensitizers with enhanced activity compared to Photofrin

May 16, 2000

Isolation, structure and biological activity of new Cdc25B tyrosine phosphatase inhibitors

May 12, 2000

Survival results promising in phase II study of 81C6 MAb in patients with recurrent brain tumors

May 12, 2000

PF-1201: new antitumor antibiotic selective for tumor gene-transformed cell lines

May 12, 2000

Kinase inhibitors under evaluation at major German pharmaceutical laboratory

May 11, 2000

Antitumor agents from American Cyanamid act by inhibiting PTKs

May 11, 2000

HMW endostatins for treatment and diagnosis of tumors disclosed by Haemopep

May 11, 2000

CDD and ICRT to collaborate on anticancer drug development

May 11, 2000

Orphan drug status awarded to arsenic trioxide for multiple myeloma

May 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...